141 related articles for article (PubMed ID: 1352699)
21. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha.
Abraham LJ; French MA; Dawkins RL
Clin Exp Immunol; 1993 Apr; 92(1):14-8. PubMed ID: 8096802
[TBL] [Abstract][Full Text] [Related]
22. HLA-DQ RFLP variants of five HLA-DQw2-bearing major histocompatibility complex extended haplotypes.
Yunis JJ; Wescott M; Lechin SJ; Alosco SM; Awdeh Z; Alper CA; Yunis EJ
Immunogenetics; 1990; 32(2):88-95. PubMed ID: 1975800
[TBL] [Abstract][Full Text] [Related]
23. Historical recombinant sites in extended HLA haplotypes.
D'Alfonso S; Bolognesi E; Mazzola G; Dall'Omo A; Richiardi PM
J Biol Regul Homeost Agents; 1999; 13(1):8-13. PubMed ID: 10432436
[TBL] [Abstract][Full Text] [Related]
24. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
25. Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis.
Varade J; Wang N; Lim CK; Zhang T; Zhang Y; Liu X; Piehl F; Matell R; Cao H; Xu X; Hammarström L
J Autoimmun; 2018 Mar; 88():43-49. PubMed ID: 29037440
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions.
Candore G; Lio D; Colonna Romano G; Caruso C
Autoimmun Rev; 2002 Feb; 1(1-2):29-35. PubMed ID: 12849055
[TBL] [Abstract][Full Text] [Related]
27. Genomic MHC haplotyping of mutant cell lines using a novel marker.
Degli-Esposti MA; Williamson JF; Tay GK; Salmon B; Joseph GA; Morley AA; Dawkins RL
Eur J Immunogenet; 1993 Oct; 20(5):373-80. PubMed ID: 9098405
[TBL] [Abstract][Full Text] [Related]
28. Extended MHC haplotypes and CYP21/C4 gene organisation in Irish 21-hydroxylase deficiency families.
Sinnott PJ; Costigan C; Dyer PA; Harris R; Strachan T
Hum Genet; 1991 Jul; 87(3):361-6. PubMed ID: 1677925
[TBL] [Abstract][Full Text] [Related]
29. Genomic organization of a polymorphic duplicated region centromeric of HLA-B.
Leelayuwat C; Abraham LJ; Tabarias H; Christiansen FT; Dawkins RL
Immunogenetics; 1992; 36(4):208-12. PubMed ID: 1353477
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune hepatitis, HLA and extended haplotypes.
Oliveira LC; Porta G; Marin ML; Bittencourt PL; Kalil J; Goldberg AC
Autoimmun Rev; 2011 Feb; 10(4):189-93. PubMed ID: 20933106
[TBL] [Abstract][Full Text] [Related]
31. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.
Tienari PJ; Tuomilehto-Wolf E; Tuomilehto J; Peltonen L
Diabetologia; 1992 Mar; 35(3):254-60. PubMed ID: 1348711
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms at positions -22 and -348 in the promoter of the BAT1 gene affect transcription and the binding of nuclear factors.
Price P; Wong AM; Williamson D; Voon D; Baltic S; Allcock RJ; Boodhoo A; Christiansen FT
Hum Mol Genet; 2004 May; 13(9):967-74. PubMed ID: 15028669
[TBL] [Abstract][Full Text] [Related]
33. DP polymorphism in HLA-A1,-B8,-DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
Bishof NA; Welch TR; Beischel LS; Carson D; Donnelly PA
Pediatr Nephrol; 1993 Jun; 7(3):243-6. PubMed ID: 8100139
[TBL] [Abstract][Full Text] [Related]
34. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
35. An extended HLA-D region haplotype associated with celiac disease.
Howell MD; Smith JR; Austin RK; Kelleher D; Nepom GT; Volk B; Kagnoff MF
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):222-6. PubMed ID: 2893373
[TBL] [Abstract][Full Text] [Related]
36. Association of four HLA class III region genomic markers with HLA haplotypes.
Pei J; Choo SY; Spies T; Strominger JL; Hansen JA
Tissue Antigens; 1991 May; 37(5):191-6. PubMed ID: 1685263
[TBL] [Abstract][Full Text] [Related]
37. Segregation of HLA haplotypes in 100 families with a myasthenia gravis patient.
van den Berg-Loonen EM; Nijenhuis LE; Engelfriet CP; Feltkamp TE; van Rossum AL; Oosterhuis HJ
J Immunogenet; 1977 Oct; 4(5):331-40. PubMed ID: 925350
[TBL] [Abstract][Full Text] [Related]
38. HLA associations with inclusion body myositis.
Garlepp MJ; Laing B; Zilko PJ; Ollier W; Mastaglia FL
Clin Exp Immunol; 1994 Oct; 98(1):40-5. PubMed ID: 7923882
[TBL] [Abstract][Full Text] [Related]
39. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201.
Congia M; Frau F; Lampis R; Frau R; Mele R; Cucca F; Muntoni F; Porcu S; Boi F; Contu L
Tissue Antigens; 1992 Feb; 39(2):78-83. PubMed ID: 1349446
[TBL] [Abstract][Full Text] [Related]
40. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.
Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
Ann N Y Acad Sci; 1998 May; 841():368-70. PubMed ID: 9668261
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
